Bioregenx (BRGX) Return on Capital Employed (2023 - 2026)

Bioregenx's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 30.47% for Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 57391.0% year-over-year to 30.47% in Q1 2026; TTM through Mar 2026 was 30.47%, a 57391.0% decrease from a year earlier, with the FY2025 full-year figure at 34.49%, down 73818.0% from the prior year.
• Return on Capital Employed fell to 30.47% in Q1 2026 per BRGX's latest filing, from 37.96% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 1771.56% in Q3 2023 and bottomed at 1841.56% in Q2 2023.
• The 4-year median for Return on Capital Employed is 30.47% (2026), against an average of 50.6%.
• Biggest YoY gain for Return on Capital Employed was 179573 bps in 2024; the steepest drop was 180458 bps in 2024.
• Year by year, Return on Capital Employed stood at 145.84% in 2023, then tumbled by 394 bps to 429.35% in 2024, then jumped by 109 bps to 37.96% in 2025, then slipped by 20 bps to 30.47% in 2026.
• Per Business Quant, the three latest BRGX Return on Capital Employed figures stand at 30.47% (Q1 2026), 37.96% (Q4 2025), and 671.26% (Q3 2025).